Gain Therapeutics (GANX) announced the formation of its Clinical Advisory Board, CAB, to support the continued development of the Company’s lead drug candidate, GT-02287, in Parkinson’s disease.

“We are delighted to welcome Skip, Markus and Niklas to our Clinical Advisory Board. Each of them has dedicated their careers to advancing the care of patients with cancer through the ...

Formation of Clinical Scientific Advisory Board Marea’s clinical scientific advisory board will complement the deep expertise of Marea Therapeutics’ leadership team, founders and board of ...

Medcura, a hemostatic devicemaker, formed a Spinal Surgery Advisory Board, according to a Jan. 16 news release.

Launching a private equity fund is an exciting yet daunting endeavor; and a General Partner (GP) Advisory Board can be a ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...